Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies

OBJECTIVES: Tofacitinib is an oral Janus kinase inhibitor for the treatment of RA. We evaluated radiographic progression in tofacitinib-treated patients with RA for up to 3 years in two pooled long-term extension (LTE) studies (ORAL Sequel; A3921041) (primary analysis), and for up to 5 years using d...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023998/
https://www.ncbi.nlm.nih.gov/pubmed/33057725
http://dx.doi.org/10.1093/rheumatology/keaa476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023998/
https://www.ncbi.nlm.nih.gov/pubmed/33057725
http://dx.doi.org/10.1093/rheumatology/keaa476

Ejemplares similares